EDS
Evan David Seigerman
#1695 out of 1699 analysts
BMO Capital
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
-99.6%
Gain
Monthly
-13.26%
Yearly
-81.87%
Drawdown
99.91%
$247.33
Equity
Holdings
$246.34
Cash
$0.99
Investment
$252.61
-$99,763.84
Profit
Realized
-$99,757.57
Unrealized
-$6.27
Dividends
$649.9
$0.99
Cash
Deposits
$100,011.17
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0%
Profit
$0
Win %
0%
This Week
Compared To Last Week
Gain
0%
Profit
$0
Win %
0%
This Month
Compared to last month
Gain
-1.71%
Profit
-$4.3
Win %
0%
This Year
Compared to last year
Gain
14.75%
Profit
$31.78
Win %
81%
REGN Regeneron Pharmaceuticals, Inc.
+0.33%
+$0.81 No Data
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 61 | Longs Won 29/57 50% | Profit Factor 0.14 |
| Profitability | Shorts Won 0/4 0% | Standard Deviation $5,021.92 |
| Average Win $554.84 | Best Trade (Sep 15) $6,381.46 | Sharpe Ratio -76.8 |
| Average Loss -$3,640.76 | Worst Trade (Mar 22) -$27,941.74 | Z-Score -0.76 (55.12%) |
| Commissions $0 | Avg. Trade Length 2m 1w 1d | Expectancy -$1,635.47 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
